Premium
S1 guideline for diagnostic evaluation in androgenetic alopecia in men, women and adolescents
Author(s) -
BlumePeytavi U.,
Blumeyer A.,
Tosti A.,
Finner A.,
Marmol V.,
Trakatelli M.,
Reygagne P.,
Messenger A.
Publication year - 2011
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/j.1365-2133.2010.10011.x
Subject(s) - guideline , medicine , expert opinion , diagnostic accuracy , family medicine , pediatrics , gynecology , dermatology , intensive care medicine , pathology
Summary Androgenetic alopecia (AGA) is the most common hair loss disorder, affecting both men and women. Due to the frequency and the often significant impairment of life perceived by the affected patients, competent advice, diagnosis and treatment is particularly important. As evidence‐based guidelines on hair disorders are rare, a European consensus group was constituted to develop guidelines for the diagnostic evaluation and treatment of AGA. This S1 guideline for diagnostic evaluation of AGA in men, women and adolescents reviews the definition of AGA and presents expert opinion‐based recommendations for sex‐dependent steps in the diagnostic procedure.